Tirzepatide
Dual GIP and GLP-1 Receptor Agonist
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Available as FDA-approved Mounjaro® for Type 2 diabetes and Zepbound® for weight management and obstructive sleep apnea. It provides superior weight loss and glycemic control compared to single-pathway medications through its unique dual mechanism of action.
Comprehensive Dosing Guide
Who Should Not Take Tirzepatide & Safety Tips
Do Not Take If:
- You or your family have a history of a certain thyroid cancer (medullary thyroid carcinoma).
- You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- You're allergic to tirzepatide or any ingredients in the medicine.
Use Carefully If:
- You've had pancreatitis (inflammation of the pancreas).
- You have eye problems related to diabetes.
- You have a history of thyroid tumors.
Medical Disclaimer
Tirzepatide is FDA-approved as Mounjaro® for Type 2 diabetes and Zepbound® for chronic weight management. This information is for educational purposes and should not replace consultation with healthcare providers. Individual results may vary. Prescribing information and medical supervision are required for all therapeutic uses.